Gemma Forner
CRISPR-Cas9 has revolutionized the field of genetic engineering with its precision and efficiency. This paper explores the application of CRISPRCas9 in cancer immunotherapy, focusing on its role in enhancing immune cell functions, targeting oncogenes, and overcoming resistance mechanisms. By modifying T cells and other immune components, CRISPR-Cas9 holds promise for developing more effective and personalized cancer treatments. We discuss recent advancements, potential challenges, and future directions in leveraging this technology for cancer immunotherapy.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 